Evidence map›Paper›PMID 36570040›Full record

ArticleJournal of communication in healthcare2017

Physician Response to Contextualized Price-Comparison Claims in Prescription Drug Advertising.

Kevin R Betts, Kathryn J Aikin, Vanessa Boudewyns, Mihaela Johnson, Alex Stine, Brian G Southwell

Open access · greenAbstract read
In one paragraph

Article in Journal of communication in healthcare, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion.Journal of the American Board of Family Medicine : JABFM · 2025
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kevin R BettsU.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993.
Kathryn J AikinU.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993.
Vanessa BoudewynsRTI International, 3040 E. Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709.
Mihaela JohnsonRTI International, 3040 E. Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709.
Alex StineRTI International, 3040 E. Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709.
Brian G SouthwellRTI International, 3040 E. Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709.
RTI International · USUnited States Food and Drug Administration · US

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

Background: Physician-targeted prescription drug advertisements sometimes include price comparisons between products that may misleadingly imply equivalence of efficacy and safety or misrepresent true savings, suggesting the potential utility of a context statement to explain what the claims do and do not mean. Methods: We manipulated the presence of a price claim and a context statement in a 1 × 3 (control condition, price-comparison-only, price-comparison-plus-context) between-subjects design. Physicians ( Results: The majority of physicians accurately recognized the price claim (76.0%) but far fewer accurately recognized the associated context statement (44.9%). The context statement did not affect evaluations of the price-comparison claim importance or accuracy and did not have the intended effects on perceptions of uncertainty about drug interchangeability. Physicians may be affected by price-comparison claims in thinking that the drug has risks that are relatively less severe. Price-comparison claims also affected intentions to look for information about the drug. Conclusions: Adding a realistic context statement to a physician-targeted prescription drug ad did not generate sufficient awareness of claim caveats to differentiate price-comparison response of those exposed to the context statement from those who were not.

Indexed as

advertising as topicdisclosurehealth communicationpharmaceutical decision makingprescription drugprice comparisonsrisk communication

Identifiers

PMID36570040
PMCPMC9788646
OpenAlexW2750251163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.